US 9023984
Diagnostic and therapeutic target for autoimmune diseases and uses thereof
granted A61PA61P3/10
Quick answer
US patent 9023984 (Diagnostic and therapeutic target for autoimmune diseases and uses thereof) held by The Regents of the University of Colorado, a Body Corporate expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P3/10